OMNIA · Orchestrating Multi-Omic Nanomedicine Insights with AI and Spatial Biology–Driven Innovation and Training for Hard-to-Treat Cancers
„Хоризонт Европа“ — Действия „Мария Склодовска-Кюри“
- Период
- 2026-09-01 → 2030-08-31
- Финансиране от ЕС
- 1 803 600 €
- Участници
- 23
- Схема
- HORIZON-TMA-MSCA-SE
Линиите свързват координатора с партньорите.
Накратко на български
Наночастиците и взаимодействието им с околната среда на трудни за лечение тумори се анализират чрез изкуствен интелект и пространствен анализ. Това помага за създаването на по-безопасни и ефективни методи за терапия срещу рака.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Цел на проекта
OMNIA is a European-led, globally connected research and training programme redefining how nanotherapeutics are designed and translated for hard-to-treat cancers. By integrating spatial multi-omics, advanced tumor models, and interpretable AI, OMNIA uncovers how nanoparticles interact with the tumor microenvironment—turning complex molecular data into actionable design rules for safer, more effective treatments.Through a harmonized nanoparticle platform, standardized SOPs, and FAIR-compliant data pipelines, OMNIA transforms fragmented nanomedicine studies into a reproducible, data-driven field. Its consortium of leading academic, clinical, and industrial partners from Europe, North America, and Asia bridges expertise in materials science, oncology, and AI to deliver open spatial atlases, validated analysis tools, and regulatory-ready templates.At its core, OMNIA is also a training ecosystem. Over 80 researchers will engage in structured, cross-sector secondments—“capsule curricula” that combine hands-on experimentation, AI analysis, and translational science. This approach cultivates a new generation of scientists fluent in materials–biology–AI integration and capable of driving Europe’s next wave of cancer nanomedicine.Organized into five interconnected work packages spanning nanoparticle design, characterization, spatial biology, AI, and ethics, OMNIA combines scientific excellence, industrial innovation, and mobility-driven collaboration—laying the foundation for a sustainable, spatially informed, AI-enabled future in nanomedicine.
Оригинален текст от CORDIS (на английски).
Участници
- ANKARA UNIVERSITESI · Tandogan AnkaraКоординаторТурция
- Augusta University Research Institute, Inc. · AugustaСъединени щати
- BLUEPHARMA - INDUSTRIA FARMACEUTICASA · CoimbraПортугалия
- CENTRE DE LUTTE CONTRE LE CANCER LEON BERARD · LyonФранция
- CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS · ParisФранция
- CSD HEALTH CARE · KYIVУкрайна
- DREXEL UNIVERSITY · PhiladelphiaСъединени щати
- FUNDACIO INSTITUT CATALA DE NANOCIENCIA I NANOTECNOLOGIA · BELLATERRA (BARCELONA)Испания
- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE · ParisФранция
- Khalifa University of Science and Technology · Abu DhabiОбединени арабски емирства
- LATVIJAS UNIVERSITATE · RIGAЛатвия
- MATERIALS RESEARCH CENTER · KievУкрайна
- PUSAN NATIONAL UNIVERSITY · BUSANЮжна Корея
- THE UNIVERSITY OF BIRMINGHAM · BirminghamОбединеното кралство
- THE UNIVERSITY OF MANITOBA · ManitobaКанада
- TURUN YLIOPISTO · TurkuФинландия
- UNIVERSIDADE DE COIMBRA · CoimbraПортугалия
- UNIVERSITA DEGLI STUDI DI PADOVA · PadovaИталия
- UNIVERSITA DEGLI STUDI DI SASSARI · SassariИталия
- UNIVERSITE LYON 1 CLAUDE BERNARD · Villeurbanne CedexФранция
- UNIVERSITY OF MIAMI · Coral Gables MiamiСъединени щати
- UNIWERSYTET IM. ADAMA MICKIEWICZA WPOZNANIU · PoznanПолша
- YOURSCIENCEBE · Bruxelles / BrusselБелгия
Връзки
Данни: CORDIS, © Европейски съюз